scispace - formally typeset
H

Hakan Oral

Researcher at University of Michigan

Publications -  335
Citations -  20534

Hakan Oral is an academic researcher from University of Michigan. The author has contributed to research in topics: Atrial fibrillation & Catheter ablation. The author has an hindex of 72, co-authored 323 publications receiving 19317 citations. Previous affiliations of Hakan Oral include Office of Technology Transfer.

Papers
More filters
Journal ArticleDOI

Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation

TL;DR: The clinical efficacy of pulmonary vein isolation is much lower when AF is persistent than when it is paroxysmal, and with a segmental isolation approach that targets at least 3 PVs, a clinically satisfactory result can be achieved in >80% of patients with paroxYSmal AF.
Journal ArticleDOI

Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

TL;DR: Sinus rhythm can be maintained long term in the majority of patients with chronic atrial fibrillation by means of circumferential pulmonary-vein ablation independently of the effects of antiarrhythmic-drug therapy, cardioversion, or both.
Journal ArticleDOI

Catheter Ablation for Paroxysmal Atrial Fibrillation Segmental Pulmonary Vein Ostial Ablation Versus Left Atrial Ablation

TL;DR: In patients undergoing catheter ablation for PAF, LACA to encircle the PVs is more effective than SOCA, and the only complication was left atrial flutter in a patient who underwent LACA.
Journal ArticleDOI

Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation

TL;DR: Atrio-esophageal fistulas can occur after catheter ablation in the posterior wall of the left atrium after radiofrequency ablation for atrial fibrillation, and this diagnosis should be excluded in any patient with symptoms or signs of endocarditis after left atrial ablation.
Journal ArticleDOI

Relationship between burden of premature ventricular complexes and left ventricular function.

TL;DR: A PVC burden of >24% was independently associated with PVC-induced cardiomyopathy and best separated the patient population with impaired as compared with preserved left ventricular function.